Evidence map›Paper›PMID 36421303›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Design of a Bacteriophage Cocktail Active against

Andrey A Filippov, Wanwen Su, Kirill V Sergueev, Richard T Kevorkian, Erik C Snesrud, Apichai Srijan, Yunxiu He, Derrick E Fouts, Woradee Lurchachaiwong, Patrick T McGann and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Broad-spectrum phage cocktail targetingFrontiers in microbiology · 2026
    Article
  2. StudiesAntimicrobial agents and chemotherapy · 2025
    Article
  3. Article
  4. Article
  5. Microorganisms · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Andrey A FilippovWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.ORCID 0000-0003-2256-861X
Wanwen SuWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Kirill V SergueevWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Richard T KevorkianWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Erik C SnesrudMultidrug-Resistant Organism Repository and Surveillance Network, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Apichai SrijanDepartment of Enteric Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.
Yunxiu HeWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Derrick E FoutsJ. Craig Venter Institute, Rockville, MD 20850, USA.ORCID 0000-0003-4323-7668
Woradee LurchachaiwongDepartment of Enteric Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.
Patrick T McGannMultidrug-Resistant Organism Repository and Surveillance Network, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Damon W EllisonBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Brett E SwierczewskiBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Mikeljon P NikolichWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.ORCID 0000-0001-5770-8980
Walter Reed Army Institute of Research · USArmed Forces Research Institute of Medical Science · THJ. Craig Venter Institute · US

Funding

Congressionally Directed Medical Research Program (Peer Reviewed Medical Research Program) PR182667Military Infectious Disease Research Program, Defense Health Program D0559_17_WRthe WRAIR command no
6 · The paper itself

Abstract

Shigellosis is a leading global cause of diarrheal disease and travelers' diarrhea now being complicated by the dissemination of antibiotic resistance, necessitating the development of alternative antibacterials such as therapeutic bacteriophages (phages). Phages with lytic activity against

Indexed as

bacteriophageGalleria mellonella infection modelphage therapeuticsShigella

Identifiers

PMID36421303
PMCPMC9686686
OpenAlexW4309787406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.